M. B. Rodal

A phase 1b study to assess the safety of PLX3397, a CSF-1 receptor inhibitor, and paclitaxel in patients with advanced solid tumors.

L. Coussens, H. Rugo, N. Sharma, 2014 .

Phase I trial of pomalidomide given for patients with advanced solid tumors

M. Cooney, R. Dreicer, A. Dowlati, 2012, Cancer Chemotherapy and Pharmacology.

A Phase I Study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer

B. Halmos, P. Fu, A. Dowlati, 2013, Investigational New Drugs.

Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors

L. Coussens, H. Rugo, N. Sharma, 2019, Therapeutic advances in medical oncology.

Phase I trial of daily pomalidomide in patients with advanced solid tumors.

M. Cooney, R. Dreicer, A. Dowlati, 2010 .